HIP1 as a marker of aggressive prostate cancer

Clinical Genetics

Volumn 62, Issue 5, 2002, Pages 368-375

  Chan, E Y W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; EPSIN; HUNTINGTIN; HUNTINGTIN INTERACTING PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG; VIRUS T ANTIGEN;

ADVANCED CANCER; APOPTOSIS; CANCER CELL CULTURE; CARCINOMA IN SITU; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; ENDOCYTOSIS; HISTOPATHOLOGY; HUMAN; METASTASIS POTENTIAL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0036873090     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620503_4.x     Document Type: Note

References (8)

1. Towbin JA. The role of cytoskeletal proteins in cardiomyopathies. Current Opinion Cell Biol 1998: 10: 131-139.
2. Baboonian C, Davies MJ, Booth JC, McKenna WJ. Coxsackie B viruses and human heart disease. Current Opinion Microbiol Immunol 1997: 223: 31-52.
3. Badorff C, Lee GH, Knowlton KU. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex. Herz 2000: 25: 227-232.
4. Hackam AS, Yassa AS, Singaraja R, et al. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem 2000: 275: 41299-41308.
5. Gervais FG, Singaraja R, Xanthoudakis S, et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nature Cell Biol 2002: 4: 95-105.
6. Metzler M, Legendre-Guillemin V, Gan L, et al. HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2. J Biol Chem 2001: 276: 39271-39276.
7. Waelter S, Scherzinger E, Hasenbank R, et al. The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis. Human Mol Genet 2001: 10: 1807-1817.
8. Kallioniemi O-P, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular pro-filing of cancer. Human Mol Genet 2001: 10: 657-662.